Cross John Harry III 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed Dec 22, 2022
Insider Transaction Report
Form 4
Cross John Harry III
Chief Financial Officer
Transactions
- Award
Common Stock
2022-12-14+15,519→ 160,684 total
Footnotes (2)
- [F1]On December 14, 2022, the Reporting Person was granted 15,519 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on January 1, 2024.
- [F2]Includes unvested RSUs.